Hendriks JMH - Search Results

1

Prognostic implications of cellular senescence in resected non-small cell lung cancer.

Domen A, Deben C, De Pauw I, Hermans C, Lambrechts H, Verswyvel J, Siozopoulou V, Pauwels P, Demaria M, van de Wiel M, Janssens A, Hendriks JMH, Van Schil P, Vermorken JB, Vandamme T, Prenen H, Peeters M, Lardon F, Wouters A. Domen A, et al. Among authors: hendriks jmh. Transl Lung Cancer Res. 2022 Aug;11(8):1526-1539. doi: 10.21037/tlcr-22-192. Transl Lung Cancer Res. 2022. PMID: 36090630 Free PMC article.

2

Single-pass isolated lung perfusion versus recirculating isolated lung perfusion with melphalan in a rat model.

Van Putte BP, Hendriks JM, Romijn S, Guetens G, De Boeck G, De Bruijn EA, Van Schil PE. Van Putte BP, et al. Ann Thorac Surg. 2002 Sep;74(3):893-8; discussion 898. doi: 10.1016/s0003-4975(02)03802-x. Ann Thorac Surg. 2002. PMID: 12238857

3

Isolated lung perfusion with gemcitabine in a rat: pharmacokinetics and survival.

Van Putte BP, Hendriks JM, Romijn S, Pauwels B, Friedel G, Guetens G, De Bruijn EA, Van Schil PE. Van Putte BP, et al. J Surg Res. 2003 Feb;109(2):118-22. doi: 10.1016/s0022-4804(02)00063-x. J Surg Res. 2003. PMID: 12643852

4

Isolated lung perfusion for the treatment of pulmonary metastases current mini-review of work in progress.

Van Putte BP, Hendriks JM, Romijn S, Van Schil PE. Van Putte BP, et al. Surg Oncol. 2003 Nov;12(3):187-93. doi: 10.1016/s0960-7404(03)00039-2. Surg Oncol. 2003. PMID: 12957622 Review.

5

Pharmacokinetics after pulmonary artery perfusion with gemcitabine.

Van Putte BP, Hendriks JM, Romijn S, Pauwels B, De Boeck G, Guetens G, De Bruijn E, Van Schil PE. Van Putte BP, et al. Ann Thorac Surg. 2003 Oct;76(4):1036-40; discussion 1040. doi: 10.1016/s0003-4975(03)00839-7. Ann Thorac Surg. 2003. PMID: 14529980

6

Isolated lung perfusion with melphalan for resectable lung metastases: a phase I clinical trial.

Hendriks JM, Grootenboers MJ, Schramel FM, van Boven WJ, Stockman B, Seldenrijk CA, ten Broecke P, Knibbe CA, Slee P, De Bruijn E, Vlaeminck R, Heeren J, Vermorken JB, van Putte B, Romijn S, Van Marck E, Van Schil PE. Hendriks JM, et al. Ann Thorac Surg. 2004 Dec;78(6):1919-26; discussion 1926-7. doi: 10.1016/j.athoracsur.2004.05.058. Ann Thorac Surg. 2004. PMID: 15561001 Clinical Trial.

7

Cellular infiltrates and injury evaluation in a rat model of warm pulmonary ischemia-reperfusion.

Van Putte BP, Kesecioglu J, Hendriks JM, Persy VP, van Marck E, Van Schil PE, De Broe ME. Van Putte BP, et al. Crit Care. 2005 Feb;9(1):R1-8. doi: 10.1186/cc2992. Epub 2004 Nov 10. Crit Care. 2005. PMID: 15693961 Free PMC article.

8

Regional differences of melphalan lung levels after isolated lung perfusion in the rat.

Romijn S, Hendriks JM, Van Putte BP, Weyler J, Guetens G, De Boeck G, Van Schil PE. Romijn S, et al. J Surg Res. 2005 May 15;125(2):157-60. doi: 10.1016/j.jss.2004.12.015. J Surg Res. 2005. PMID: 15854668

9

Anterograde versus retrograde isolated lung perfusion with melphalan in the WAG-Rij rat.

Romijn S, Hendriks JM, Van Putte BP, Weyler J, Guetens G, De Boeck G G, De Bruijn EA, Van Schil PE. Romijn S, et al. Eur J Cardiothorac Surg. 2005 Jun;27(6):1083-5. doi: 10.1016/j.ejcts.2005.02.015. Epub 2005 Apr 2. Eur J Cardiothorac Surg. 2005. PMID: 15896622

10

Combination chemotherapy with gemcitabine with isolated lung perfusion for the treatment of pulmonary metastases.

Van Putte BP, Hendriks JM, Romijn S, Pauwels B, Vermorken JB, Van Schil PE. Van Putte BP, et al. J Thorac Cardiovasc Surg. 2005 Jul;130(1):125-30. doi: 10.1016/j.jtcvs.2004.07.045. J Thorac Cardiovasc Surg. 2005. PMID: 15999051 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page